consolidated financial statements of the Company as of June 30, 2017 and the audited financial statements of Symbior as of December 31, 2016, and on the criteria according to the Notification of the Capital
: .............................................................Juristic Person Registration No............................... head office located at
. Audit Firm Profile Name: .............................................................Juristic Person Registration No............................... head office located at
. +66 2 654 3344 Fax. +66 2 654 3323 www.pacedev.com Registration No. 0107554000232 บมจ. เพซ ดีเวลลอปเมนท์ คอรป์อเรชัน่ 87/2 ซีอาร์ซี ทาวเวอร์ ออลซีซัน่เพลส ชั้น 45 ยูนิต 3 ถนนวิทยุ แขวงลุมพนิี เขตปทุมวัน
and submit financial statements and reports on its financial position and operating results to the SEC Office; (3) an issuing company whose registration statement and draft prospectus have been filed
shareholders’ meeting. (As shown in the Attachment No.2) 2. That the audited financial statements for the year ended December 31, 2019, be approved. 3. Non-allocation of net profit as legal reserve and the
value of consideration basis. The highest transaction value is derived from this method of calculation, whereby the, calculation is based on the Company’s reviewed consolidated financial statements for
by the total value of consideration equivalent is 14.57%, calculated by the net tangible assets method according to the consolidated financial statements of the Company as of September 30, 2018 and
.............................................................................................. I hereby certify that the above statements and the supplementary documentation attached herewith are complete, accurate and true. Concurrently, the applicant has provided a copy of the certification